Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Update on nitrosamines in EU medicines 3 March 2020Press releaseHumanReferrals EMA organisational changes come into effect 2 March 2020NewsCorporateGovernance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020 28 February 2020NewsHumanGeneric and hybrid medicinesMedicinesReferrals Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 February 2020 21 February 2020Press releaseVeterinaryMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2020 14 February 2020NewsHumanPharmacovigilanceQuality of medicinesReferrals Restrictions in use of cyproterone due to meningioma risk 14 February 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals Public access to suspected side effect reports of veterinary medicines 12 February 2020NewsVeterinaryPharmacovigilance New video launched: How does EMA support SMEs? 6 February 2020NewsHumanVeterinary Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-23 January 2020 6 February 2020Press releaseVeterinaryMedicines EMA to support development of vaccines and treatments for novel coronavirus disease (COVID-19) 4 February 2020Press releaseHumanCOVID-19Vaccines 1 … 89 90 91 92 93 Page 93 of 380 94 95 96 97 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020 28 February 2020NewsHumanGeneric and hybrid medicinesMedicinesReferrals
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 February 2020 21 February 2020Press releaseVeterinaryMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2020 14 February 2020NewsHumanPharmacovigilanceQuality of medicinesReferrals
Restrictions in use of cyproterone due to meningioma risk 14 February 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals
Public access to suspected side effect reports of veterinary medicines 12 February 2020NewsVeterinaryPharmacovigilance
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-23 January 2020 6 February 2020Press releaseVeterinaryMedicines
EMA to support development of vaccines and treatments for novel coronavirus disease (COVID-19) 4 February 2020Press releaseHumanCOVID-19Vaccines